M1 macrophages can destroy cancer cells by phagocytosis, whereas M2 macrophages, characterized by the expression of CD163 or CD206 on their cell surface, promote tissue repair and angiogenesis and favor tumor progression by producing anti-inflammatory cytokines [7]. Here, MRC1 is linked to neoplasm.